Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.
about
Urinary biomarkers of smokers' exposure to tobacco smoke constituents in tobacco products assessment: a fit for purpose approachBiomarkers of Tobacco Exposure: Summary of an FDA-sponsored Public WorkshopPrevalence and impact of active and passive cigarette smoking in acute respiratory distress syndrome.Nicotine and Toxicant Exposure among U.S. Smokeless Tobacco Users: Results from 1999 to 2012 National Health and Nutrition Examination Survey DataTime to first cigarette predicts 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in adolescent regular and intermittent smokers, National Health and Nutrition and Examination Survey (NHANES) 2007-10.Nicotine and carcinogen exposure after water pipe smoking in hookah bars.Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention.A comparative study of systemic carcinogen exposure in waterpipe smokers, cigarette smokers and non-smokers.Urine cotinine underestimates exposure to the tobacco-derived lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in passive compared with active smokers.Biomarkers of Exposure to New and Emerging Tobacco and Nicotine Delivery Products.Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smokingExposure to Nicotine and Selected Toxicants in Cigarette Smokers Who Switched to Electronic Cigarettes: A Longitudinal Within-Subjects Observational Study.Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patients.The ratio of a urinary tobacco-specific lung carcinogen metabolite to cotinine is significantly higher in passive than in active smokers.Nicotine, carbon monoxide, and carcinogen exposure after a single use of a water pipe.Assessing exposure to tobacco-specific carcinogen NNK using its urinary metabolite NNAL measured in US population: 2011-2012.Exposure to secondhand smoke outside of a bar and a restaurant and tobacco exposure biomarkers in nonsmokers.Alaska Native smokers and smokeless tobacco users with slower CYP2A6 activity have lower tobacco consumption, lower tobacco-specific nitrosamine exposure and lower tobacco-specific nitrosamine bioactivation.Cigarette Smoke Exposure and the Acute Respiratory Distress Syndrome.Racial differences in the relationship between tobacco dependence and nicotine and carcinogen exposure.Comparison of nicotine and carcinogen exposure with water pipe and cigarette smokingBiomarkers of secondhand smoke exposure in automobilesRole of biomarkers in understanding and treating children with asthma: towards personalized care.Correlates of NNAL levels among nondaily and daily smokers in the college student population.Exposure and Metabolic Activation Biomarkers of Carcinogenic Tobacco-Specific Nitrosamines.Nicotelline: a proposed biomarker and environmental tracer for particulate matter derived from tobacco smoke.Cotinine and tobacco-specific carcinogen exposure among nondaily smokers in a multiethnic sample.Biomarkers of Secondhand Smoke Exposure in Waterpipe Tobacco Venue Employees in Istanbul, Moscow, and Cairo.Urinary NNAL in hookah smokers and non-smokers after attending a hookah social event in a hookah lounge or a private home.Tobacco product use patterns, nicotine and tobacco-specific nitrosamine exposure: NHANES 1999-2012.Analysis of self-reported versus biomarker based smoking prevalence: methodology to compute corrected smoking prevalence rates.Thirdhand smoke contamination in hospital settings: assessing exposure risk for vulnerable paediatric patients.NNAL exposure by race and menthol cigarette use among U.S. smokers.Direct analysis of tobacco-specific nitrosamine NNK and its metabolite NNAL in human urine by LC-MS/MS: evidence of linkage to methylated DNA lesions.Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products.Reference change values in concentrations of urinary and salivary biomarkers of exposure and mouth level exposure in individuals participating in an ambulatory smoking study.Comparison of Urine 4-(Methylnitrosamino)-1-(3)Pyridyl-1-Butanol and Cotinine for Assessment of Active and Passive Smoke Exposure in Urban Adolescents.Associations between smoking and lipid/lipoprotein concentrations among US adults aged ≥20 years.Adolescent Exposure to Toxic Volatile Organic Chemicals From E-Cigarettes
P2860
Q28662000-C7C4BA2B-3A76-4DD9-B57C-25D38B24C8ECQ29248704-C85B4F02-7EE5-44AC-89AA-983DE9E781E2Q30371072-8D4B4DCC-C187-4C88-9B6B-24C5F8E9BEDCQ31025978-E8B9D280-9A21-40BA-9D27-2EACB89A8476Q33579037-C3837F1F-C506-48C9-9536-32EE62818CB8Q33719341-2A3534D1-69C2-41EE-A100-87B5466D3421Q33936367-C4AECF79-B73E-4B2F-B5E8-D471E8889054Q34062268-FF8006C4-FA27-42C5-8E23-DB390940025CQ34293201-B5049D91-63EA-4E6C-AA2D-D7288FB2FF1DQ34556938-C989A330-21F5-4AA9-9EDB-BB18B824542EQ34608572-9799553C-5847-437E-A493-190F29694B12Q34678680-80C31C7B-1FFB-4453-B9C3-9420C3DA9716Q35140572-5ADD9325-0215-48E4-94DF-79F00A0E1048Q35175672-7B1B1484-A0D6-483A-9640-797A39F6569DQ35535816-8C6F78C8-6651-4239-8DBC-0965F09BCC27Q35904621-DC2E15F0-1A17-482B-A81C-C4AC7D6D4150Q36115380-2B926AC4-5D8B-4A96-B807-A501EF296B37Q36499756-5474563C-E18F-4613-931D-E2CE7A477ACBQ36533745-06181F8A-6755-488F-8318-BA2401FBA0ECQ36556906-E51D78E7-4A77-4289-A619-D89C8A0F8FD1Q36831859-FD4945C8-1580-473E-B519-9A877A2BAEF9Q36897574-737769BC-AF77-438D-8A4E-12F96DEFF7CFQ37140629-DF40B311-C045-4923-B003-CD096E62BDD5Q37350891-B5C48367-20B6-4260-94B5-C5982E9504B3Q37499926-156A1C06-809B-4327-9246-90B8F3F28177Q37593895-E2E938B0-EB2A-4963-B20A-7AD320A873AAQ37705535-EE516AF1-322F-44C0-AE67-FBC6A2AE5140Q38402167-B00C685D-25C7-43E5-A501-33F49F0DE760Q38675025-F6BD9081-5AA9-4CDD-9469-776C1D33F11BQ38678266-B887A016-2775-46CB-B02D-94DB3239221AQ38775664-22BBD131-0C01-4448-8D16-B6CF65D21DE8Q38935523-A5C777CA-2092-478E-82CF-0E393395DFD7Q43581266-C798C171-5F8B-4765-85D8-FEFCB9FFF3CFQ45788050-5C48B6D4-A272-40E8-9AB3-1803345C95CCQ49346082-623BAA57-9826-436F-8FF6-CB4876738A05Q53608869-2BD2A3E5-37B6-43BA-AE5E-A0ADE4A4A04CQ53702522-C1F4525F-3716-4B57-A7B6-A66729A22361Q55086539-745743DD-5CEF-43F2-AA40-7D94EFA41CB8Q57255797-0BB52F18-6133-49FA-A6A6-7FAC5DC93746
P2860
Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-
@nl
Elimination kinetics of the to ...... mino)-1-(3-pyridyl)-1-butanol.
@ast
Elimination kinetics of the to ...... mino)-1-(3-pyridyl)-1-butanol.
@en
type
label
Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-
@nl
Elimination kinetics of the to ...... mino)-1-(3-pyridyl)-1-butanol.
@ast
Elimination kinetics of the to ...... mino)-1-(3-pyridyl)-1-butanol.
@en
prefLabel
Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-
@nl
Elimination kinetics of the to ...... mino)-1-(3-pyridyl)-1-butanol.
@ast
Elimination kinetics of the to ...... mino)-1-(3-pyridyl)-1-butanol.
@en
P2093
P2860
P1476
Elimination kinetics of the to ...... mino)-1-(3-pyridyl)-1-butanol.
@en
P2093
Bartosz Koszowski
Christopher M Havel
Delia Dempsey
Jan Czogala
Maciej L Goniewicz
Margaret Wilson Peng
Neal L Benowitz
Peyton Jacob
Wioleta Zielinska-Danch
P2860
P304
P356
10.1158/1055-9965.EPI-09-0874
P577
2009-12-01T00:00:00Z